SYRE logo

Spyre Therapeutics (SYRE) EV/EBITDA

EV/EBITDA

-4.80
+0.23+4.57%

Thu, 13 Mar 2025 20:45:54 GMT


Summary


Performance

SYRE EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherSYREvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

SYRE EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+4.6%-4.5%-4.2%
1 m1 month+23.8%-23.9%-22.3%
3 m3 months+33.0%-28.5%-26.4%
6 m6 months+42.7%-31.0%-38.4%
ytdytd+21.4%-21.4%-20.0%
1 y1 year+58.4%-32.1%-60.7%
5 y5 years-194.5%+657.4%-84.9%

SYRE EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-1.1%-6.30+23.8%
3 m3-month-4.75-1.1%-7.60+36.8%
6 m6-month-4.75-1.1%-10.47+54.1%
1 y1-year-2.74-75.2%-11.80+59.3%
3 y3-year2.67-279.8%-11.80+59.3%
5 y5-year2.67-279.8%-11.80+59.3%
alltimeall time2.67-279.8%-11.80+59.3%

Spyre Therapeutics EV/EBITDA History

DateValue
2025
-4.80(-21.4%)
2024
-6.11(+32.8%)
2023
-4.60(<-9900.0%)
2022
0.01(-100.3%)
2021
-3.50(-3.8%)
DateValue
2020
-3.64(+40.0%)
2019
-2.60(-25.9%)
2018
-3.51(+24.5%)
2017
-2.82(+475.5%)
2016
-0.49

FAQ

  • What is Spyre Therapeutics EV/EBITDA?
  • What is the all time high EV/EBITDA for Spyre Therapeutics?
  • What is SYRE EV/EBITDA year-to-date change?
  • What is Spyre Therapeutics EV/EBITDA year-on-year change?

What is Spyre Therapeutics EV/EBITDA?

The current EV/EBITDA of SYRE is -4.80

What is the all time high EV/EBITDA for Spyre Therapeutics?

Spyre Therapeutics all-time high EV/EBITDA is 2.67

What is SYRE EV/EBITDA year-to-date change?

Spyre Therapeutics EV/EBITDA has changed by +1.31 (+21.44%) since the beginning of the year

What is Spyre Therapeutics EV/EBITDA year-on-year change?

Over the past year, SYRE EV/EBITDA has changed by +6.75 (+58.44%)